Plural Ring Hetero Atoms In The Heptacyclo Ring System Patents (Class 546/36)
-
Patent number: 5852030Abstract: A novel compound which is a .delta.-opioid antagonist having high selectivity and activity, that exhibits immunosuppressive action, antiallergic action, anti-inflammatory action and brain cell-protecting action is disclosed. The compound according to the present invention is an indole derivative represented by the formula (I): ##STR1## and pharmaceutically acceptable acid addition salts thereof. The present invention also provides an immunosuppressive agent, antiallergic agent, anti-inflammatory agent and brain cell-protecting agent comprising the derivative or the salt as an effective ingredient.Type: GrantFiled: September 10, 1996Date of Patent: December 22, 1998Assignee: Toray Industries, Inc.Inventors: Hiroshi Nagase, Akira Mizusuna, Koji Kawai, Izumi Nakatani
-
Patent number: 5756744Abstract: Photoconductive imaging members comprised of unsymmetrical dimeric perylene as a charge generator, wherein said perylene is of the following formula ##STR1## wherein R is hydrogen, alkyl, cycloalkyl, substituted alkyl, aryl, substituted aryl, aralkyl or substituted aralkyl group, and X--Y is an unsymmetrical bridging moiety of alkylene, substituted alkylene, arylene, substituted arylene, aralkylene or substituted aralkylene.Type: GrantFiled: July 29, 1997Date of Patent: May 26, 1998Assignee: Xerox CorporationInventors: James M. Duff, C. Geoffrey Allen, Ah-Mee Hor, Gordon K. Hamer
-
Patent number: 5622957Abstract: A compound selected from those of general formula (I): ##STR1## wherein A represents a bivalent radical ##STR2## and R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.6, R.sub.7, R.sub.8, R.sub.9 and Z are as defined in the description,the isomers and pharmaceutically-acceptable acid or base addition salts thereof, and medicinal products containing the same which are useful in the treatment of depression and anxiety.Type: GrantFiled: May 3, 1995Date of Patent: April 22, 1997Assignee: Adir et CompagnieInventors: Jean-Daniel Brion, Claude Thal, Luc Demuynck, Jean-Gilles Parmentier, Jean Lepagnol, Pierre Lestage, Jean-Fran.cedilla.ois Pujol, Pascal Schmitt, Pierre Potier
-
Patent number: 5536728Abstract: A novel 4-acylaminopyridine derivative represented by the following formula (I) is disclosed. ##STR1## The 4-acylaminopyridine derivative of the present invention is useful as a medicine for treating disturbances of memory such as senile dementia and Alzheimer's disease, since it has an action of directly activating malfunctioned cholinergic neuron.Type: GrantFiled: December 8, 1994Date of Patent: July 16, 1996Assignee: Mitsubishi Chemical CorporationInventors: Kunihiro Ninomiya, deceased, Ken-ichi Saito, Mamoru Sugano, Akihiro Tobe, Yasuhiro Morinaka, Tomoko Bessho, Haruko Harada
-
Patent number: 5397785Abstract: A novel 4-acylaminopyridine derivative represented by the following formula (I) is disclosed. ##STR1## The 4-acylaminopyridine derivative of the present invention is useful as a medicine for treating disturbances of memory such as senile dementia and Alzheimer's disease, since it has an action of directly activating malfunctioned cholinergic neuron.Type: GrantFiled: September 2, 1993Date of Patent: March 14, 1995Assignee: Mitsubishi Kasei CorporationInventors: Kunihiro Ninomiya, deceased, Ken-ichi Sato, Mamoru Sugano, Akihiro Tobe, Yasuhiro Morinaka, Tomoko Bessho, Haruko Harada
-
Patent number: 5259988Abstract: A polycyanamide compound represented by the general formula (I): ##STR1## wherein A is ##STR2## X is an integer ranging from 10 to 30. This polycyanamide compound of the formula (I) is a photoelectric material and, in this respect, can be used for photovoltaic cells, macromolecular cells and functional elements such as photo sensors.Type: GrantFiled: December 3, 1992Date of Patent: November 9, 1993Assignee: Korea Institute of Science and TechnologyInventors: Sang W. Park, Kyung H. Yoo, Yong K. Kang, Young H. Lee, Hyung Y. Kim, Hyon T. Kwak, Yeong I. Lee
-
Patent number: 5232915Abstract: 9.alpha.-Hydroxy-19,11.beta.-bridged steroids of general formula I ##STR1## are described. The more detailed meaning of A, B, R.sup.1, R.sup.2, G, Z, R.sup.4 --Y and R.sup.4' --Y' follows from the description. The steroids of general formula I have antigestagen and/or antiglucocorticoidal action and can be used for the production of pharmaceutical agents.Type: GrantFiled: January 14, 1992Date of Patent: August 3, 1993Assignee: Schering AktiengesellschaftInventors: Eckhard Ottow, Gunter Neef, Rudolf Wiechert, Walter Elger, Sybille Beier, Karl-Heinrich Fritzemeier
-
Patent number: 5194088Abstract: A process for converting crude pigments into pigmentary form wherein the crude pigment is premilled, then contacted with a polar solvent at temperatures below 50.degree. C., with or without the presence of particle growth inhibitors, and finally isolated.Type: GrantFiled: July 8, 1991Date of Patent: March 16, 1993Assignee: Ciba-Geigy CorporationInventors: Fridolin Babler, Edward E. Jaffe
-
Patent number: 5096907Abstract: This disclosure describes novel antibacterial agents designated LL-E10985.alpha., LL-E19085.beta., LL-E19085.gamma., LL-E19085.gamma. and LL-E19085.zeta., having the structure: ##STR1## their production by aerobic fermentation of a new subspecies of Micromonospora citrea NRRL 18351 and mutants thereof, and the isolation and purification thereof.Type: GrantFiled: January 9, 1991Date of Patent: March 17, 1992Assignee: American Cyanamid CompanyInventors: Guy T. Carter, Joseph J. Goodman, David P. Labeda
-
Patent number: 4986852Abstract: Pigments of the formula I ##STR1## where A is a five- or six-membered aromatic fused or unfused heterocycle which contains one to three hetero atoms from the series consisting of nitrogen and/or oxygen and/or sulfur and which is bonded to the methylene group via a carbon atom, R.sub.1 and R.sub.2 are each hydrogen, alkyl C.sub.1 -C.sub.4, alkylene C.sub.2 or aryl, and together R.sub.1 and R.sub.2 may also be an aliphatic or aromatic ring, R.sub.3 is hydrogen, alkyl C.sub.1 -C.sub.4 hydroxylkyl C.sub.1 -C.sub.3 or alkylene C.sub.2, P is the radical of a polycyclic pigment or a radical of a mix-crystal of polycyclic pigments, and n is a number from 0.0001 to 0.Type: GrantFiled: December 20, 1988Date of Patent: January 22, 1991Assignee: Hoechst AktiengesellschaftInventors: Erwin Dietz, Gustav Kapaun, Michael Kappert, Frank Prokschy, Adolf Kroh, Manfred Urban
-
Patent number: 4886884Abstract: The present invention is to provide a novel cervinomycin derivative represented by formula ##STR1## wherein ring B represents ##STR2## at least one of R.sub.1, R.sub.2 and R.sub.3 represents an acyl group or an alkyl group and the others represent a hydrogen atom; and R.sub.4 is a hydrogen atom or an alkyl group, and a process for producing said derivatives. The present derivative is free from the problems of the conventional cervinomycin, i.e., the low solubility in various solvents, high toxicity, and low activity against Gram-positive bacteria.Type: GrantFiled: October 19, 1987Date of Patent: December 12, 1989Assignee: The Kitazato InstituteInventors: Satoshi Omura, Akira Nakagawa, Yuzuru Iwai
-
Patent number: 4874803Abstract: The present invention comprises reaction products resulting from the reaction of hydrazido-substituted or certain amino-substituted polymer stabilizers and cyclic dianhydrides, as well as the use of such products. The polymer stabilizers of the invention are useful for protecting a large variety of synthetic polymeric organic materials from the degradative effects of heat, light and oxygen. Some of the modifiers are flame retardants and many are metal deactivators in addition to their primary activity.Type: GrantFiled: September 21, 1987Date of Patent: October 17, 1989Assignee: Pennwalt CorporationInventors: Arthur L. Baron, Terry N. Myers, Jerome Wicher
-
Patent number: 4866069Abstract: Disclosed are a compound of the general formula ##STR1## wherein R.sub.1 and R.sub.2 are the same or different and each represents a hydrogen atom, an alkyl group or an acyl group, process for the production thereof and use thereof. The compounds have an antitumor activity, and those wherein both of R.sub.1 and R.sub.2 represent a hydrogen atom or an acyl group are novel compounds.Type: GrantFiled: October 3, 1988Date of Patent: September 12, 1989Assignee: Taiho Pharmaceutical Company, LimitedInventors: Qi Chang-qing, Tian Jie, Teruyoshi Marunaka, Yuji Yamada, Ichiro Yamawaki, Toshio Ohtani, Yoshinori Minami, Hitoshi Saito
-
Patent number: 4814449Abstract: Disclosed are a compound of the general formula ##STR1## wherein R.sub.1 and R.sub.2 are the same or different and each represents a hydrogen atom, an alkyl group or an acyl group, process for the production thereof and use thereof. The compounds have an antitumor activity, and those wherein both of R.sub.1 and R.sub.2 represent a hydrogen atom or an acyl group are novel compounds.Type: GrantFiled: May 11, 1987Date of Patent: March 21, 1989Assignee: Taiho Pharmaceutical Company, LimitedInventors: Qi Chang-qing, Tian Jie, Teruyoshi Marunaka, Yuji Yamada, Ichiro Yamawaki, Toshio Ohtani, Yoshinori Minami, Hitoshi Saito
-
Patent number: 4758664Abstract: Process for the preparation of linear quinacridones of the formula (1) ##STR1## in which R denotes a hydrogen, fluorine, chlorine or bromine atom or a C.sub.1 -C.sub.6 -alkyl, C.sub.1 -C.sub.3 -alkoxy or phenyl group or a fused benzene ring or a phenylamino or phenoxy group which can be substituted on the aromatic nucleus by fluorine, chlorine or bromine atoms or C.sub.1 -C.sub.4 -alkyl groups, and n denotes a number from 0 to 2, it being possible, in the event that n.noteq.0, for the substituents R present on the same benzene ring or on the two benzene rings to be identical or different, by the oxidation of linear 6,13-dihydroquinacridones of the formula (2) ##STR2## in which R and n have the meanings mentioned above, which comprises heating, at temperatures from about 180.degree. C. to about 280.degree. C., 1 mole of the last-mentioned compounds with 1 to 2 moles of iodine in a high-boiling organic solvent which is inert towards the reactants.Type: GrantFiled: May 1, 1986Date of Patent: July 19, 1988Assignee: Hoechst AktiengesellschaftInventors: Ernst Spietschka, Frank Prokschy
-
Patent number: 4316027Abstract: Dye intermediates of the formula ##STR1## where R.sup.1 is hydrogen, alkyl of 1 to 12 carbon atoms, phenyl which is unsubstituted or substituted by alkyl of 1 to 4 carbon atoms, methoxy, ethoxy, chlorine or bromine, or phenylalkyl of 7 to 10 carbon atoms, R.sup.2 is hydrogen or R.sup.1 and R.sup.2 together are dimethylene, trimethylene or tetramethylene, which are unsubstituted or substituted by alkyl of 1 to 12 carbon atoms, R.sup.3 and R.sup.5 are hydrogen, alkyl of 1 to 12 carbon atoms, cyano-, chlorine-, methoxy- or ethoxy-substituted alkyl of 2 to 4 carbon atoms, cycloalkyl of 5 to 7 carbon atoms, phenylalkyl of 7 to 10 carbon atoms or trimethylene which is unsubstituted or substituted by 1 to 3 methyl and is bonded to the carbon atom in the 6-position or 6'-position of the benzene ring, R.sup.4 and R.sup.Type: GrantFiled: April 6, 1978Date of Patent: February 16, 1982Assignee: BASF AktiengesellschaftInventors: Hans Baumann, Andreas Oberlinner
-
Patent number: 4167506Abstract: A group of novel polynuclear heterocyclic compounds having a diazaphenalene skeleton. These compounds assume orange to reddish violet colors according to the types of substituents on the diazaphenalene skeleton, and have excellent thermal stability and weatherability and good dispersibility in polymeric materials. They are useful as orange to reddish violet pigments, especially for coloring polymeric materials.Type: GrantFiled: September 13, 1977Date of Patent: September 11, 1979Assignee: Teijin LimitedInventors: Keizo Shimada, Toshiaki Harada, Masahiro Koga, Shizuo Nagahama, Hiroyoshi Minematsu, Hidetsugu Yoshida